Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

as lawmakers this year have approved proposals with an additional $436 million for further expansion aimed at addressing overcrowding. The new buildings will replace three of the four existing ...

Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge ...